Literature DB >> 32294237

The role of mitochondrial dynamics in cardiovascular diseases.

Maurizio Forte1, Leonardo Schirone2,3, Pietro Ameri4,5, Cristina Basso6, Daniele Catalucci7,8, Jessica Modica7,8, Cristina Chimenti9, Lia Crotti10,11,12, Giacomo Frati1,2, Speranza Rubattu1,13, Gabriele Giacomo Schiattarella14,15, Daniele Torella16, Cinzia Perrino15, Ciro Indolfi16, Sebastiano Sciarretta1,2.   

Abstract

The process of mitochondrial dynamics is emerging as a core player in cardiovascular homeostasis. This process refers to the co-ordinated cycles of biogenesis, fusion, fission and degradation to which mitochondria constantly undergo to maintain their integrity, distribution and size. These mechanisms represent an early response to mitochondrial stress, confining organelle portions that are irreversibly damaged and preserving mitochondrial function. Accumulating evidence demonstrates that impairment in mitochondrial dynamics leads to myocardial damage and cardiac disease progression in a variety of disease models, including pressure overload, ischaemia/reperfusion and metabolic disturbance. These findings suggest that modulation of mitochondrial dynamics may be considered as a valid therapeutic strategy in cardiovascular diseases. In this review, we discuss the current evidence about the role of mitochondrial dynamics in cardiac pathophysiology, with a particular focus on the mechanisms underlying the development of cardiac hypertrophy and heart failure, metabolic and genetic cardiomyopathies, ischaemia/reperfusion injury, atherosclerosis and ischaemic stroke.
© 2020 The British Pharmacological Society.

Entities:  

Year:  2020        PMID: 32294237     DOI: 10.1111/bph.15068

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

Review 1.  Aging of Vascular System Is a Complex Process: The Cornerstone Mechanisms.

Authors:  Anastasia V Poznyak; Nikolay K Sadykhov; Andrey G Kartuesov; Evgeny E Borisov; Vasily N Sukhorukov; Alexander N Orekhov
Journal:  Int J Mol Sci       Date:  2022-06-22       Impact factor: 6.208

Review 2.  Mitochondria and Doxorubicin-Induced Cardiomyopathy: A Complex Interplay.

Authors:  Leonardo Schirone; Luca D'Ambrosio; Maurizio Forte; Riccardo Genovese; Sonia Schiavon; Giulia Spinosa; Giuliano Iacovone; Valentina Valenti; Giacomo Frati; Sebastiano Sciarretta
Journal:  Cells       Date:  2022-06-22       Impact factor: 7.666

Review 3.  Interplay between Zn2+ Homeostasis and Mitochondrial Functions in Cardiovascular Diseases and Heart Ageing.

Authors:  Siarhei A Dabravolski; Nikolay K Sadykhov; Andrey G Kartuesov; Evgeny E Borisov; Vasily N Sukhorukov; Alexander N Orekhov
Journal:  Int J Mol Sci       Date:  2022-06-21       Impact factor: 6.208

4.  Editorial: Mitochondrial Metabolism in Ischemic Heart Disease.

Authors:  Lei Yang; Shijun Wang; Jian Wu; Lei-Lei Ma; Yang Li; Haiyang Tang
Journal:  Front Cardiovasc Med       Date:  2022-06-27

Review 5.  Myocardial regeneration protocols towards the routine clinical scenario: An unseemly path from bench to bedside.

Authors:  Nadia Salerno; Luca Salerno; Fabiola Marino; Mariangela Scalise; Antonio Chiefalo; Giuseppe Panuccio; Antonella De Angelis; Eleonora Cianflone; Konrad Urbanek; Daniele Torella
Journal:  EClinicalMedicine       Date:  2022-06-27

Review 6.  Mitochondrial Quality Control in the Heart: The Balance between Physiological and Pathological Stress.

Authors:  Giovanni Fajardo; Michael Coronado; Melia Matthews; Daniel Bernstein
Journal:  Biomedicines       Date:  2022-06-10

Review 7.  Calpains as Potential Therapeutic Targets for Myocardial Hypertrophy.

Authors:  David Aluja; Sara Delgado-Tomás; Marisol Ruiz-Meana; José A Barrabés; Javier Inserte
Journal:  Int J Mol Sci       Date:  2022-04-07       Impact factor: 6.208

8.  Adrenergic Receptor Regulation of Mitochondrial Function in Cardiomyocytes.

Authors:  Peyton B Sandroni; Kelsey H Fisher-Wellman; Brian C Jensen
Journal:  J Cardiovasc Pharmacol       Date:  2022-09-01       Impact factor: 3.271

Review 9.  Iron overload cardiomyopathy: Using the latest evidence to inform future applications.

Authors:  Sirinart Kumfu; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Exp Biol Med (Maywood)       Date:  2022-02-07

Review 10.  Molecular mechanisms and clinical implications of multiple forms of mitophagy in the heart.

Authors:  Toshiro Saito; Kimikazu Hamano; Junichi Sadoshima
Journal:  Cardiovasc Res       Date:  2021-12-17       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.